Skip to main content
Equibles

PERKINS CAPITAL MANAGEMENT INC

Position in DYAI — Dyadic International Inc

CIK 884300 WAYZATA, MN
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$43,245
+$3,844 QoQ
Shares Held
48,050
0.0% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#16
of 39 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PERKINS CAPITAL MANAGEMENT INC holds $2,091,815 across 5 Biotechnology names. DYAI ranks #5 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CDXS
Codexis, Inc.
 526,100 $1,188,986
2 CELC
Celcuity Inc.
 4,500 $470,790
3 MRNA
Moderna, Inc.
 4,000 $280,120
4 PBYI
Puma Biotechnology, Inc.
 13,400 $108,674
5 DYAI
Dyadic International Inc
This page 		48,050 $43,245

All Filings in DYAI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $43,245 48,050
2026-03-31 $39,401 48,050
2025-12-31 $323,746 344,411
2025-09-30 $410,699 348,050
2025-06-30 $47,371 47,850
2025-03-31 $64,597 47,850
2024-12-31 $83,737 47,850
2024-09-30 $49,764 47,850
2024-06-30 $70,818 47,850
2024-03-31 $79,909 47,850
2023-12-31 $77,038 47,850
2023-09-30 $91,872 47,850
2023-06-30 $92,350 47,850
2023-03-31 $85,618 48,100
2022-12-31 $59,163 48,100
2022-09-30 $91,871 48,100
2022-06-30 $146,705 48,100
2022-03-31 $144,781 48,100
2021-12-31 $217,412 48,100
2021-09-30 $268,548 48,300
2021-06-30 $173,397 48,300
2021-03-31 $261,873 47,700
2020-12-31 $228,650 42,500
2020-09-30 $321,725 42,500
2020-03-31 $221,000 42,500